U.S. Markets closed

Pernix Therapeutics Holdings, Inc. (PTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.60-0.02 (-0.76%)
At close: 4:00PM EDT

2.78 +0.16 (6.11%)
After hours: 6:35PM EDT

People also watch
EBIOXGTISKLNSPHSGEVO
  • C
    Carlos
    Carlos
    Group One Trading sold all its shares 19945
    Bank of New York Mellon sold all its shares 24553
    KCG Holding sold all its shares 28739
  • P
    Pharmaherooooooo
    Pharmaherooooooo

    SNOA (MC $23 M) (Cash $13 M) Shares Out: 4.3 M /Undiscovered Stock/ Lots of Marketed Products some of them are in early launch phase plus additional Product launches expected within 6 months / Profitable in 2018 = 1000%+ UPSIDE POTENTIAL..GLTA

    Sonoma Pharma (Nasdaq: SNOA)

    Market Cap: 22.1 Million
    Cash: $12.6 Million
    Price: $5.15

    Shares Out : 4.3 Million

    Presentation
    http://ir.sonomapharma.com/common/download/download.cfm?companyid=ocls&fileid=945547&filekey=F57B6874-6CD1-4205-A160-8E08BBB7A928&filename=SonomaPharma_Investor_presentation_13June2017.pdf

    Fact Sheet
    http://files.shareholder.com/downloads/OCLS/4977255852x0x231236/39d834a3-8462-40ee-8650-e0945b6facd5/Sonoma_Fact_Sheet.pdf

    Driving to commercial EBITDAS breakeven, without dilution

    Grow current product portfolio with all sales people

    •Alevicyn HydroGel, Dermal Spray & Spray Gel for atopic dermatitis & dermal procedures •Celacyn for scar treatment
    •Mondoxyne for severe acne –launched late 2015
    •Ceramax for skin repair in atopic dermatitis–launched in April 2016
    •SebuDerm for seborrhea dermatitis –launched in November 2016

    Launch 3 New Products –our product pipeline –one every other quarter

    •Launching Loyon–Fall 2017
    •Ceramax in foam and gel forms –Q4 2017 & Q1 2018

    Launch and Grow New and Current Products: During fiscal year 2017, we launched four new dermatology products, including SebuDerm™, Ceramax™, Lasercyn™ Gel and Lasercyn™ Dermal Spray, bringing us to a total of eight dermatology products for the treatment of atopic and seborrheic dermatitis, scar management, surgical procedures, severe acne and “state of the art” skin repair technology. We also obtained three new FDA clearances, now totaling 16 overall. Our strong intellectual property portfolio consists of 63 issued patents and 33 patent applications pending.

    We plan to launch our new FDA approved product Loyon® (a skin descaler currently marketed in Europe) in the upcoming months and have a strong product pipeline of several product line improvements, including a line extension of Ceramax™. All in all, we believe this could possibly be our best product line of new FDA approved dermatology and skincare products yet, and we believe our innovation plan will help lead us to profitability.

  • C
    Carlos
    Carlos
    CLASSIC
    SEDOR JOHN A receives 10000 shares
    MIAO GRAHAM G receives 8000 shares
    PINA KENNETH receives 6000 shares
    And a small new GOLEMBIEWSKI MICHAEL gets to start 3300 shares.
    Before receiving shares, let them prove themselves by bringing the finances of PTX in positive!
  • C
    Carlos
    Carlos
    When under 2?
  • C
    Carlos
    Carlos
    This company is dead. Manipulation, only to take your money!
  • N
    Natalie
    Natalie
    Downside risk pretty much eliminated now I would guess, thoughts? Im not sure about you guys but awe-som*sto-cks has provided me with some pretty good trade ideas. I messed up executing some of them but thats on me.
  • E
    Emily
    Emily
    Is PTX undervalued? This sort of setup suggests potential upside... awe-som_sto-cks recently alerted this company i think. google them.
  • H
    Harv
    Harv

    Found a great no fee daytrading newsletter, vist www.T0pm@rketgainers.c0m and sign up...so glad I did.

  • C
    Carlos
    Carlos
    End of year BK, reversplit or Pinksheet?
  • B
    Bruno
    Bruno
    Why is this stock always up big in the After Hours and down big during Regular Trading?
  • G
    Greg
    Greg
    what a total disaster this stock has been the last couple months. Is there a bottom anywhere??
  • G
    Gabriel
    Gabriel
    What's up with the after hours the past 2 days? Shooting up on 1 share traded after hours?
  • C
    Carlos
    Carlos
    Next week under $1.83. You will see.
  • C
    Carlos
    Carlos
    Whouaw, every day a decrease of 3 to 5%. That smell no good!
  • p
    p
    p
    buyout awaits...dont mind waiting another few weeks or months ..2 .max....buying all I can at this very stupid piece...sb 12 now
  • C
    Carlos
    Carlos
    I do not know until they want to get off. But I'm ready to buy!
  • B
    Bruno
    Bruno
    Tomorrow: Up 15% to $3.55.
  • T
    TOM
    TOM
    is it the opiod situation that is causing all this or is there other problems why would anyone buyout this thing ???
  • N
    Nick
    Nick
    Anyone have any new info? Looking a little bleak right now.
  • p
    p
    p
    shorts will start to cook tomorrow as news.of Trex note refi and asset sale AND note payoff come at same moment...25 price target